A public-private partnership between ARPA-H and VentureWell in support of the ARPANET-H nationwide health innovation network. Website is maintained by VentureWell staff.
Are you attending J.P. Morgan Healthcare Conference? Find out what events we are attending, meet 1:1 with the ARPA-H Investor Catalyst Hub team, or request a meeting with ARPA-H leadership by filling out this form.
OmniSync and its TurboSBIR technology are well known for helping innovators find and successfully apply for non-dilutive capital opportunities, such as SBIR/STTR funding opportunities. Building a strong SBIR/STTR proposal team is important for SBIR/STTR success. Through this webinar, attendees will learn how to assemble a strong SBIR/STTR proposal team and how to prove your team’s […]
Learn about Dr. Tina Boville’s experience spinning out Aralez Bio in 2019 from her postdoctoral research at Caltech while working with Nobel Laureate Prof. Frances Arnold. Dr. Boville will share her story translating a novel enzymatic pathway for synthesizing non-canonical amino acids into a platform startup for efficient, scalable, and sustainable production of valuable chemicals […]
Ileana Hancu, Ph.D., ARPA-H Program Manager for the Precision Surgical Interventions (PSI) program, will join us to give an overview of her program and how entities can contribute at different […]
The ARPA-H HEalth care Rewards to Achieve Improved OutcomES (HEROES) Program has launched! Join us for a HEROES Ask-Me-Anything informational webinar with Program Manager Darshak Sanghavi, M.D., and learn about everything from program objectives and milestones to opportunities for funding and engagement. We’ll reserve the full session for Q&A—don’t miss the chance to be among […]
Preparing administrative documents is among the most tedious, confusing, and frustrating parts of the Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) process. On Tuesday, February 20, at 10 a.m. PT, join […]
We will be joined by Daria Fedyukina, Ph.D., ARPA-H Program Manager, who specializes in translational science and commercialization strategies involving cell and gene therapies, and Stan Wang, M.D., Ph.D., Founder […]